Cancer experts will gather today for the 2025 Beaumont RCSI Cancer Centre Conference at the RCSI Education and Research Centre in Beaumont Hospital, Dublin. This year’s theme, ‘Transforming Cancer Care: Innovation, Integration, and Equity’ will examine themes of healthcare outcomes, and equity and access in cancer diagnostics and cancer research.

Jointly hosted by RCSI and Beaumont Hospital, this annual conference highlights leading-edge approaches to cancer diagnosis and treatment, while reinforcing the critical importance of equitable access to care across all populations.

Speaking about the event, Professor Patrick Morris, Medical Director of the Beaumont RCSI Cancer Centre, said: “Examining the global backgrounds and varied needs of cancer patients is crucial in tailoring effective cancer treatment strategies. This conference will provide an opportunity to share insights and exchange ideas that will advance worldwide cancer care, and ensure it is accessible and equitable for all.”  

The opening keynote address will be presented by Professor Linda Sharpe, Professor of Cancer Epidemiology at the University of Newcastle. Leader of the research programme at the National Cancer Registry Ireland for ten years she was also Senior Lecturer in Epidemiology at the University of Aberdeen. 

The other keynote speaker presenting at the event is Professor Arsela Prelaj, who is a Consultant Oncologist in Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, specialising in thoracic malignancies. She is head of the hospital’s Artificial Intelligence for Oncology Lab and President of the European Interdisciplinary Society of AI for Cancer Research of AI in Cancer Research.

The event’s other distinguished speakers include Professor Gerry Hanna, Consultant Radiation Oncologist, Marie Curie Chair of Clinical Oncology, Trinity St James' and St Luke's Radiation Oncology Network; Dr Helen Greally, National Clinical Lead in Psycho-Oncology, Director of Psychology and Psychosocial supports at Cancer Care West; Dr Sudipto Das, Deputy Dean, Senior Lecturer, School of Pharmacy and Biomolecular Sciences, RCSI; Mr William Robb; Consultant Upper GI Surgeon, Robotic Surgery, Beaumont RCSI; and Professor Brendan Doyle, Consultant Histopathologist, Digital Pathology, Beaumont RCSI.

Claire Noonan, Chief Operations Officer of Beaumont, said: “The Beaumont RCSI Cancer Conference provides an important space for experts to convene and discuss the latest innovations and technological advances in cancer treatment. This conference serves as a key forum to share insights and exchange ideas that will not only advance cancer care, but also ensure it is accessible and equitable for all.”

The Beaumont RCSI Cancer Conference continues to serve as a collaborative platform for academic and clinical leaders to influence national and international policy and practice.

The 2025 programme built on the momentum of previous years by expanding its focus to encompass digital innovation, global health equity, and the role of interdisciplinary collaboration in transforming outcomes.